Charles G Drake, MD, PHD
Charles G Drake, MD, PHD

Charles G Drake, MD, PHD

Medical Oncology
phone icon
phone icon
Internal Medicine, Medical Oncology, more

Locations and Appointments

New Patients

CUIMC/Herbert Irving Pavilion

161 Fort Washington Avenue
New York, NY 10032
Call to ScheduleNew and Existing Patients
Existing Patients
Login or sign-up to Connect Patient Portal to make an appointment
Existing Patients
Login to Connect Patient Portal make an appointment, view documentation or contact your doctor’s office.
NYP Connect App
The NYP Connect App allows you to access convenient services to help manage your health. Access the patient portal, communicate with your doctor, manage appointments, view test results, request prescription refills, pay a bill, and find a doctor.

insurance icon
Insurances Accepted

Please contact the doctor's office to verify that your insurance is accepted.

  • Affinity Health Plan
  • AgeWell
  • Amida Care
  • Emblem/GHI
  • Emblem/Hip
  • Empire Blue Cross Blue Shield Healthplus
  • Empire Blue Cross/Blue Shield
  • Fidelis Care
  • Healthfirst
  • Local 1199
  • Magnacare (National)
  • Medicare
  • Multiplan
  • MVP Health Care
  • Quality Health Management
  • RiverSpring
  • UnitedHealthcare
  • WellCare
  • World Trade Center Health Plan

about icon
About Charles G Drake, MD, PHD

Dr. Charles G. Drake is a physician-scientist with a Ph.D. in immunology, whose work focuses on understanding and fighting advanced-stage cancers with the immune system. He is known for rapidly incorporating discoveries made in the research lab into innovative clinical trials, including anti-tumor vaccines. The Drake laboratory was the first group to show that LymphocyteActivation Gene–3 (LAG-3) is a cell surface marker for CD4 cells with regulatory function (Treg) and that blockade of LAG-3 with a monoclonal antibody could restore anti-tumor immune responses by mitigating CD8 T-cell tolerance in vivo. Further work demonstrated that LAG-3 and PD-1 were co-expressed on functionally exhausted CD8 T cells, suggesting that blockade of multiple immune checkpoints might be required to restore anti-tumor immunity. These discoveries were then translated into clinical trials. His most recent work has focused on the body’s immunological response to radiation therapy and how immunotherapy and radiation therapy can be used in concert to treat cancer. His research has been published in prestigious journals such as the New England Journal of Medicine, Cancer Research, the Journal of Clinical Investigation, and the Journal of Clinical Oncology. Prior to joining NewYork-Presbyterian/Columbia, Dr. Drake served as the co-director of the Cancer Immunology Program at Johns Hopkins Kimmel Cancer Center. He is also a professor of oncology, urology, and immunology. As co-director of the Prostate Cancer Multi-Disciplinary Clinic, he developed a novel transgenic model of prostate cancer, in which a unique antigen is expressed exclusively in the prostate gland and in prostate tumors. Dr. Drake received both his bachelor’s degree in electrical engineering and his master’s degree in biomedical engineering from Rutgers University. He completed a Ph.D. program at the National Jewish Center for Immunology and Respiratory Medicine at the University of Colorado Health Sciences Center, and later earned his M.D. from the University of Colorado as part of the MSTP program. He did his internship and residency in internal medicine at the Osler Medical Service of Johns Hopkins Hospital, and did his medical oncology fellowship training in the Johns Hopkins Department of Oncology.

list icon


  • Clinical Research Trials

  • Genitourinary Cancer

  • Immunology

list icon


  • Fellowship: Johns Hopkins Hospital

  • Internship: Johns Hopkins Hospital

  • Residency: Johns Hopkins Hospital

list icon

Titles & Positions

  • Co-Director, Cancer Immunotherapy Programs

  • Co-leader, Tumor Biology and Microenvironment Program.

  • Professor of Medicine

list icon

Hospital Affiliations

  • NewYork-Presbyterian / Columbia University Irving Medical Center


  • Internship: Johns Hopkins Hospital
  • Residency: Johns Hopkins Hospital
  • Fellowship: Johns Hopkins Hospital

Awards & Honors

  • 1984 Eta Kappa Nu - Electrical Engineering Honor Society
  • 1984, 1985 Deans List, Rutgers University College of Engineering
  • 1993 Viola Vestal Coulter Foundation Scholarship for Graduate Research
  • 1993, 1994 Award For Outstanding Research; University of Colorado Student Research Forum
  • 1994 E.E. Osgood Award For Highest Ranked Abstract by a Student. Western Society for Clinical Research
  • 1996 Election to Alpha Omega Alpha (AOA) - Medical Honor Society
  • 1997 American College of Physicians Student Abstract Competition(Clinical Vignette Award)
  • 1997 Edward Stoiber Scholar Award for Outstanding Scholarship during All Four Medical School Years
  • 2001 Aventis Fellow - Johns Hopkins Department of Oncology
  • 2004 Damon Runyon - Lilly Clinical Investigator Award
  • 2006 Director's Teaching Award in Clinical Science; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
  • 2006 V Foundation - Scholar Award
  • 2010 Prostate Cancer Foundation - Creativity Award
  • 2011 Society for Immunotherapy for Cancer- Volunteer Recognition Award
  • 2013 Director's Teaching Award in Laboratory-Based Cancer Research; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
  • 2015 Resident's Teaching Award, The Brady Urological Institute at Johns Hopkins

Titles & Positions

  • Co-Director, Cancer Immunotherapy Programs
  • Co-leader, Tumor Biology and Microenvironment Program.
  • Professor of Medicine